School of Pharmacy

Dr. Nicholas Ferencz

Dr. Nicholas Ferencz

Director of Pharmacy Practice Laboratories; Assistant Professor

Levine Health Sciences 356

704-233-8360

nferencz@wingate.edu


Education
University of Mississippi, PharmD
Tulane University, PhD
The Ohio State University, MS
Case-Western Reserve University, MSLS
Cleveland State University, BA
The Ohio State University, BS

About Me

The most important times each year for me have always been when school started and when school ended. When school ended, I looked forward to various employment. When school began, I looked forward to the rigors of formal education.

Even when lengths of employment got longer and schooling shorter, I still looked forward to my next episode of formal education. Perhaps that is why, when employed as the owner/manager of a pharmacy, a professor in a pharmacy school, a basic researcher in pharmacology, a director of pharmacy in several large hospitals, and again as a professor in a pharmacy school, I’ve acquired the degrees I’m proud to hold. I see no greater vocation than teaching what I have spent my life learning.



Safety of automated dispensing systems. US Pharm, 2014.

Urinary excretion of 6-OH-Chlorzoxazone is formation rate limited. Clin Pharmacol Ther, 1995.

Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity. Clin Pharmcol Ther, 1995.

Plasma, cerebrospinal fluid and brain pharmacokinetics of 2 novel prodrugs of zidovudine. Antimicrob Chemother, 1993.

Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus. Clin Pharmacol Ther, 1991.

Perturbation of inulin and gallamine pharmacokinetics by phenylephrine and nitroprusside. Clin Pharmacol Ther, 1990.

Creating standard treatment protocols: … Hosp Form, 1987.

Building a structured learning package. Con Pharm Prac, 1982.

Behavioral objectives for a hospital pharmacy residency. Am J Hosp Pharm, 1977.
Red tape for the sick. Wall Street Journal, 1973.




An international randomized double-blind study evaluating a number of anticoagulants. Proprietary Report Presentation, 2003.

Phase II trials of a number of chemotherapies for patients with refractory multiple myeloma. Proprietary Report Presentation, 2002.

Clinical pharmacokinetics modeling for hospitalized patients. Proprietary Report Presentation, 1996.

Study of nabumetone pharmacokinetics in healthy human subjects. Proprietary Report Presentation, 1992.
Plasma, cerebrospinal fluid and brain pharmacokinetics of novel AZT analogs. Am Fed Clin Res, 1990.

Pharmacokinetics of ribavirin in asymptomatic HIV-infected patients. NIH ACTG Scientific Session, 1989.

Blood glucose levels during parenteral hyperalimentation. ASHP Midyear Meeting, 1985.

Common drug-induced vitamin deficiencies. APhA Annual Meeting, 1980.

Clinical practice for the pharmacist. Geigy/PMA Visiting Professorship, 1980.

Effect of the estrogen PPI on patient compliance. ASHP Midyear Meeting, 1978.




Research Grants for Proprietary Drug Studies, 1994 – 2003

Research Grant, Nabumetone Pharmacokinetics, 1993

U.S. Department of Defense Post-Doctoral Fellowship in Clinical Pharmacology, Tulane University, 1991

U.S. Public Health Service Pre-Doctoral Fellowship in Pharmacology, Tulane University, 1986

Election to Omicron Delta Kappa, Northeast Louisiana University College of Pharmacy, 1983

Excellence in Teaching Award, Northeast Louisiana University College of Pharmacy, American Heart Association, 1982

Residency in Pharmacy, The Ohio State University, 1976

Pharmacy Service Award, Cleveland Visiting Nurses Association, 1973